Cefotaxime ("Claforan') in routine hospital use.
A multi-centre study was carried out in 327 patients with a wide variety of moderate to severe infections. Patients were treated with cefotaxime at the recommended dosages and, in most cases, as the sole antibiotic. The bacteriological eradication rate was 83% while 92% of clinically assessable cases were successful; 3% of cases relapsed and 5% failed to respond. There was a low incidence of side-effects.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000302:isolation & purification; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002439:Cefotaxime / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged
D002439:Cefotaxime